India's First Biosimilar Rule Requiring Tie To Brands Takes Effect Aug. 15
This article was originally published in PharmAsia News
Executive Summary
India biotechs such as Avasthagen, Biocon, Panacea Biotec and others, as of Aug. 15, will have to show their generic drugs are copies of branded versions that already have marketing approval in India.